Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Carpenter

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Chemosphere|September 13, 2024
Effects of perfluoroalkyl sulfonic acids on developmental, physiological, and immunological measures in northern leopard frog tadpolesJillian Rohonczy, Mark R Forbes, Ève A M Gilroy, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access SettingDavid J Carpenter, Divya Natesan, R Warren Floyd, et al.
Journal of Radiosurgery and SBRT|August 1, 2024
Impact of <i>TP53</i> mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgeryJim X Leng, Chang Su, David J Carpenter, et al.
Advances in Radiation Oncology|June 20, 2025
Multi-institutional Outcomes after Stereotactic Radiosurgery for Gastrointestinal Brain MetastasesJamiluddin J Qazi, David J Carpenter, Jim Leng, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|October 28, 2023
Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancerDavid J Carpenter, Pranalee Patel, Donna Niedzwiecki, et al.
Advances in Radiation Oncology|August 13, 2025
Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases CohortChristina C Huang, David J Carpenter, Jim Leng, et al.
Neuro-Oncology Advances|January 7, 2026
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasisJamiluddin J Qazi, Amanda E D Van Swearingen, David J Carpenter, et al.
Advances in Radiation Oncology|July 2, 2026
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain MetastasesJim X Leng, Muzamil Arshad, David J Carpenter, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Chemosphere|September 13, 2024
Effects of perfluoroalkyl sulfonic acids on developmental, physiological, and immunological measures in northern leopard frog tadpolesJillian Rohonczy, Mark R Forbes, Ève A M Gilroy, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|November 25, 2022
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access SettingDavid J Carpenter, Divya Natesan, R Warren Floyd, et al.
Journal of Radiosurgery and SBRT|August 1, 2024
Impact of <i>TP53</i> mutations on brain metastasis control in non-small cell lung cancer patients undergoing stereotactic radiosurgeryJim X Leng, Chang Su, David J Carpenter, et al.
Advances in Radiation Oncology|June 20, 2025
Multi-institutional Outcomes after Stereotactic Radiosurgery for Gastrointestinal Brain MetastasesJamiluddin J Qazi, David J Carpenter, Jim Leng, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|October 28, 2023
Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancerDavid J Carpenter, Pranalee Patel, Donna Niedzwiecki, et al.
Advances in Radiation Oncology|August 13, 2025
Clinical Parameters Associated With Intracranial Progression Burden Following an Initial Stereotactic Radiosurgery Course in a Multi-institutional Brain Metastases CohortChristina C Huang, David J Carpenter, Jim Leng, et al.
Neuro-Oncology Advances|January 7, 2026
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasisJamiluddin J Qazi, Amanda E D Van Swearingen, David J Carpenter, et al.
Advances in Radiation Oncology|July 2, 2026
Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain MetastasesJim X Leng, Muzamil Arshad, David J Carpenter, et al.
Pageof 6